| 2-H | Gain of chromosome 1q in patients with acute myeloid leukemia with RAM-immunophenotype associated with worse outcome | Aida Richardson | |
| 2-OTH | Evaluation of Unmethylated and Methylated DNA as a Biomarker for Target Cell Death in an Autoimmune Disease: A ddPCR approach | Sheetal Golem | |
| 3-H | Rare indels in exon 9 of CALR - a large health system experience | Juan Luis Gomez Marti | |
| 4-I | Incorporation of Tumor Neoantigen Load Enhances Immunotherapy Response Prediction | Robert Burns | |
| 5-H | Association Between B-Cell Marker Expression & RUNX1 Lesions in Acute Myeloid Leukemia, Beyond RUNX1::RUNX1T1 fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia- B/myeloid | Giby George | |
| 7-H | Clinicopathologic features of myeloid neoplasms harboring double mutated JAK2, MPL or CALR | Rong He | |
| 7-ST | SECRETORY CARCINOMA OF THE MINOR SALIVARY GLAND OR MUCOUS RETENTION CYST? WHAT IS THE CORRECT DIAGNOSIS? | Mark Shlapobersky | |
| 10-ST | Implementation of an ISO15189 Accredited Next Generation Sequencing (NGS) Service for Cell-Free Total Nucleic Acid (cfTNA) Analysis to Facilitate Driver Mutation Reporting in Plasma | Reiltin Werner | |
| 11-H | Analysis of -Globin Cluster Crossover Variants Using Long-Read Sequencing | Aruna Rangan | |
| 13-H | Fine-Tuning Sensitivity: Establishing an Optimal Framework for Measurable Residual Disease Detection in Acute Myeloid Leukemia at 0.01 | Niamh OConnor | |
| 14-ST | Detection of common hotspot variants in PIK3CA and TP53 using AGENA ClearSEEK on the MassARRAY System | Alexander Sartori | |
| 14-H | Development of an Objective Software for Capillary-Based T-Cell Receptor Gamma Gene Rearrangements (TCRG) | Chris Conner | |
| 19-H | Next Generation Sequencing of Hereditary Red Cell Disorders | Aruna Rangan | |
| 21-H | Harnessing the Power of Cell Lineage Analysis for Captivating Insights into Engraftment Monitoring and Clinical Outcome in Allogeneic Hematopoietic Transplant | Pramath Kakodkar | |
| 22-ST | Characterization of Circulating Tumor Cells for Early Detection of Minimal Residual Disease in Colorectal Cancer. A Pilot Study | Nadia Prisant | |
| 23-ST | Implementing a panel for detecting fusion in sarcomas using the nCounter platform in a middle-income country. | Rui Reis | |
| 24-H | Performance Comparison of Nine Different Assays Between Next-Generation-Sequencing (NGS) Platforms | Austin Jacobsen | |
| 25-ST | KRAS Codon 12 Mutations are Uniquely Associated with Reduced MSI-High/MMR-deficiency Rates in Colorectal Adenocarcinomas | Bryan Iorgulescu | |
| 26-ST | Molecular Subtypes in Muscle-invasive Urothelial Bladder Cancer (MIBC): comparison of two sequencing methods, evaluation of their predictive role in adjuvant chemotherapy and impact of tumor-microenvironment | Henning Reis | |
| 28-ST | Clinicopathological Features of Small Intestinal Adenocarcinomas with Microsatellite Instability in the United States | Richard Yang | |
| 33-ST | Discovery of biomarkers of brain metastasis using next generation cytogenomics on formalin-fixed paraffin-embedded head and neck squamous cell carcinomas | Stephen Eacker | |
| 41-ST | Utility of a Laboratory-Developed Liquid Biopsy Assay to Assess Response of Esophageal Carcinoma to Neoadjuvant Therapy: Preliminary Patient Cohort | Lloyd Hutchinson | |
| 42-ST | Optical Genome Mapping for Neuroblastoma | Panieh Terraf | |
June 24-26, 2024 Madrid

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|